| Peter T Campbell, Christina C Newton, Eric J Jacobs, Marjorie L McCullough, Ying Wang, Erika Rees-Punia, Mark A Guinter, Neil Murphy, Jill Koshiol, Ahmed N Dehal, Thomas Rohan, Howard Strickler, Jessica Petrick, Marc Gunter, Xuehong Zhang, Katherine A McGlynn, Michael Pollak, Alpa V Patel, Susan M Gapstur. Prospective associations of hemoglobin A1c and c-peptide with risk of diabetes-related cancers in the Cancer Prevention Study-II Nutrition Cohort. Cancer Res Commun. 2022 Jul;2(7):653-662. | download |
| Parisotto, M., Vuong-Robillard, N., Kalegari, P., Meharwade, T., Joumier, L., Igelmann, S., Bourdeau, V., Rowell, M. C., Pollak, M., Malleshaiah, M., Schmitzer, A., & Ferbeyre, G. (2022). The NAMPT Inhibitor FK866 Increases Metformin Sensitivity in Pancreatic Cancer Cells. Cancers, 14(22), 5597. | download |
|
Kenneth C Anderson, Lewis C Cantley, Riccardo Dalla-Favera, Chi Van Dang, Luis A Diaz, Raymond N DuBois, Keith T Flaherty, Philip D Greenberg, Massimo Loda, Elaine R Mardis, Elizabeth A Platz, Michael N Pollak, Robert D Schreiber, Lillian L Siu, Beverly A Teicher. The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission. Cancer Discov. 2022 Nov 2;12(11):2475-2481. Cancer Epidemiol Biomarkers Prev. 2022 Nov 2;31(11):1995-2001. Cancer Immunol Res. 2022 Nov 2;10(11):1282-1288. Blood Cancer Discov. 2022 Nov 2;3(6):469-475. Cancer Res. 2022 Nov 2;82(21):3861-3867. Clin Cancer Res. 2022 Nov 1;28(21):4593-4599. Cancer Prev Res (Phila). 2022 Nov 1;15(11):705-712. |
|
| Raymond N DuBois, Michael N Pollak. Introducing Cancer Center Director Perspectives on Prevention. Cancer Prev Res (Phila). 2022 Nov 1;15(11):713-714. | download |
| Eisenberg ER, Weiss A, Prakash I, Skamene S, Basik M, Boileau JF, Ajjamada L, Pollak MN, Wong SM. Surgical Management and Contralateral Breast Cancer Risk in Women with History of Radiation Therapy for Hodgkin Lymphoma: Results from a Population-Based Cohort. Ann Surg Oncol. 2022 Oct;29(11):6673-6680. | download |
| Lindsay A. Broadfield, Amna Saigal, Jake C. Szamosi, Joanne A. Hammill, Ksenia Bezverbnaya, Dongdong WangJaya, Gautam, Evangelina Tsakiridis, Fiorella DiPastena, Jamie McNicol, Jianhan Wu, Saad Syed, James S.V. Lally, Amogelang R. Raphenya, *Marie-Jose Blouin, Michael Pollak, Andrea Sacconi, Giovanni Blandino, Andrew G. McArthur, Jonathan D. Schertzer, Michael Surette, Stephen M. Collins, Jonathan L. Bramson, Paola Muti, Theodoros Tsakiridis, Gregory R. Steinberg. Metformin-induced reductions in tumor growth involves modulation of the gut microbiome. Molecular Metabolism. 2022 Jul 61;101498. | download |
| *Oro Uchenunu, Alexander V Zhdanov, Phillipe Hutton, Predrag Jovanovic, *Ye Wang, Dmitry E Andreev, *Laura Hulea, *David J Papadopoli, Daina Avizonis, Pavel V Baranov, Michael N Pollak, Dmitri B Papkovsky, Ivan Topisirovic. Mitochondrial complex IV defects induce metabolic and signaling perturbations that expose potential vulnerabilities in HCT116 cells. FEBS Open Bio. 2022 May;12(5):959-982. | download |
| Ying Wang, Susan M Gapstur, Christina C Newton, Marjorie L McCullough, Michael N Pollak, Peter T Campbell. Biomarkers of glucose homeostasis and inflammation with risk of prostate cancer: A case-cohort study. Cancer Epidemiol Biomarkers Prev. 2022 Apr 1;31(4):736-743. | download |
|
Altaf Mohammed, Roderick H. Dashwood, Sally Dickinson, Mary L. Disis, Elizabeth M. Jaffee, Bryon D. Johnson, Samir N. Khleif, Michael N. Pollak, Jeffrey Schlom, Robert H. Shoemaker, Sasha E. Stanton, Georg T. Wondrak, Ming You, Hao Zhu, Mark Steven Miller. Translational Advances in Cancer Prevention Agent Development (TACPAD) Virtual Workshop on Immunomodulatory Agents: Report. J Cancer Prev 26(4):309-317, December 30, 2021. |
download |